https://www.selleckchem.com/pr....oducts/pf-03084014-p
care and VL suppression while reducing workload in health facilities.Lipid perturbations contribute to detrimental outcomes in obesity. We previously demonstrated that nervonic acid, a C241 ω-9 fatty acid, predominantly acylated to sphingolipids, including ceramides, are selectively reduced in a mouse model of obesity. It is currently unknown if deficiency of nervonic acid-sphingolipid metabolites contribute to complications of obesity. Mice were fed a standard diet, a high fat diet, or these diets supplemented isocaloric
Curtir
Comentario
Compartilhar
